| Article | Added |
|---|
| Firefly Bags $500K from Massachusetts Life Science Center for miRNA Biomarker Platform | 05-24-12 |
| IMI Launches ?223.7M Industry-Academia Program to Tackle Antibiotic Resistance | 05-24-12 |
| Nexavar Fails to Meet Primary Endpoint in Late-Stage NSCLC Study | 05-23-12 |
| France's Biotech Industry Faces Financing Challenge but Partnership Growth | 05-23-12 |
| Nexavar Fails to Meet Primary Endpoint in Phase III NSCLC Study | 05-23-12 |
| Shire Reports Positive Phase III Data to Support European Filing of ADHD Drug Vyvanse | 05-23-12 |
| Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant | 05-23-12 |
| Takeda Consolidates California Research Operations in San Diego | 05-22-12 |
| AstraZeneca Eyes Collaborations, M&As, Private Investors to Boost Pipeline | 05-21-12 |
| Majority in GEN Poll Sees at Least Some Use for Bioeconomy Blueprint | 05-18-12 |
| Janssen Reports Positive Phase III Data for Chronic Diabetic Peripheral Neuropathy Analgesic | 05-18-12 |
| Osiris Wins Race to Market a Stem Cell Product with Canadian Go-Ahead | 05-18-12 |
| Poll Respondents Divided on Impact of FDA Legislation on Investing Environment | 05-17-12 |
| Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial in RCC | 05-17-12 |
| Pfizer's Torisel Misses Endpoints in Renal Cell Carcinoma Trial Testing Second-Line Setting | 05-16-12 |
| Six Firms Commit £14.4M in University of Dundee's Division of Signal Transduction Therapy | 05-16-12 |
| Pfizer's Torisel Misses Endpoints in Renal Cell Carcinoma Trail Testing Second-Line Setting | 05-16-12 |
| Six Suitors Join Bristol-Myers in Considering a Bid for Amylin | 05-15-12 |
| New UMass Accelerator to Focus on Growing Biomanufacturing | 05-14-12 |
| GSK, HGS Saddle Up for Acquisition Battle Valuing HGS at $2.6B | 05-10-12 |
| NCCN Foundation Announces 2012 Young Investigator Awards | 05-09-12 |
| GEN Poll Respondents 'somewhat? Optimistic VC Market Will Improve This Year | 05-09-12 |
| Beckman Coulter to Start Sequencing Clinical Samples | 05-09-12 |
| CHI, BCG Issue Report on FDA's Drug Review Performance | 05-09-12 |
| Beckman Coulter to Start Sequencing on Clinical Samples | 05-09-12 |
| mAb Therapeutics for Alzheimer Disease Unlikely to Be Fully Successful, According to GEN Poll | 05-08-12 |
| Eleven Increases Series A Fundraising to $45M for Protein Therapeutics Pipeline | 05-08-12 |
| Investors Remain Cool to Dendreon after Q1 Results | 05-08-12 |
| Eleven Increses Series A Fundraising to $45M for Protein Therapeutics Pipeline | 05-08-12 |
| Sutro Adds $16.5M to Series C Financing to Further Antibody Platforms | 05-08-12 |
| NIH's NCATS Establishes $20M Collaborative Drug Repositioning Initiative | 05-04-12 |
| University of Miami's Interdisciplinary Stem Cell Institute Awarded $10M | 05-04-12 |
| Affymetrix Drops Purchase Price for eBioscience to $315M | 05-04-12 |
| USTPO Affirms Key Claims of Gevo's ?AFT? Patent | 05-03-12 |
| Corcept Therapeutics Announces First Quarter Results and Corporate
and Development Update | 05-03-12 |
| Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland | 05-03-12 |
| Oxford Nanopore to Pocket £31.4M to Advance Single-Molecule Detection Technology | 05-03-12 |
| Sanofi Pasteur's Quadrivalent Flu Vaccine Succeeds in Phase III Pediatric Study | 05-02-12 |
| Shareholders to Investigate Hologic's $3.72B Deal for Gen-Probe | 05-01-12 |
| More than Half of GEN Poll Respondents Side With President Obama Over Ryan on Budget Size | 05-01-12 |
| Pall to Sell Blood Collection, Filtration, Processing Assets to Haemonetics for $550M | 04-30-12 |
| Senate Appropriations Approves FDA Budget for FY 2013 | 04-30-12 |
| Jazz Negotiates $650M Acquisition of EUSA to Take Over Marketed ALL Therapy Erwinaze | 04-27-12 |
| Icahn Drops His Proxy War Against Amylin after Meeting With CEO | 04-26-12 |
| End Users Drive Design of Grant Instruments? New Range of Heated Circulators and Baths | 04-26-12 |
| Pierre Fabre, Forest Report Positive Data from Third Phase III Depression Trial | 04-26-12 |
| GEN Poll Points to Belief that Success Rates for Biologics Will Grow | 04-25-12 |
| Takeda's Type 2 Diabetes Therapies Set Back Again by FDA | 04-26-12 |
| House, Senate Propose Budget Breakdown for NSF, NIST, and OSTP | 04-25-12 |
| Judge Sets May 10 Court Hearing for Icahn's Proxy War with Amylin | 04-24-12 |
| Amgen Ponies Up $700M for Turkey's Mustafa Nevzat | 04-25-12 |
| FDA Clears Leica's Her2 Immunohistochemical Assay on Bond-Max Instrument | 04-25-12 |
| Vectura, Novartis' COPD Therapy Succeeds in Fourth Phase III Study | 04-24-12 |
| Merck Serono to Close Geneva Headquarters, Relocate Functions to Darmstadt | 04-24-12 |
| MiRagen Pockets $20M to Further miRNA-Based Drugs | 04-24-12 |
| Poll Majority Confident that Massachusetts Can Maintain Biopharma Construction Boom | 04-23-12 |
| BTG Reports Positive Results from Second Phase III Varicose Veins Study | 04-23-12 |
| Oligomerix Raises $2M for Tau Protease Inhibitor Alzheimer Disease Program | 04-23-12 |
| Merck KGaA Sitting Out M&A Dance to Focus Instead on Cuts, Pipeline | 04-20-12 |
| Acorda Eyes Additions to Neurodegenerative Disease Drug Pipeline | 04-18-12 |
| Alder Scores $38M to Be Used for Its Two Clinical-Stage mAb Therapeutics | 04-19-12 |
| Illumina Announces Preliminary Voting Results for 2012 Annual Meeting of Stockholders | 04-18-12 |
| Valeant to Purchase Certain Assets from Atlantis Pharma in Mexico | 04-18-12 |
| Abbott's Parkinson Therapy Benefits On and Off Times in Phase III Trial | 04-18-12 |
| With Acquisition of Bayer Imaging R&D Portfolio, Piramal Continues Shift to Pharma IP | 04-17-12 |
| Roche Reports Sales Dip in First Quarter of This Year | 04-12-12 |
| Shire to Purchase Substantially All Pervasis Assets to Fortify Regenerative Medicine Business | 04-12-12 |
| GEN Poll Majority Favors Moratorium on Synthetic Bio Products | 04-10-12 |
| VC Firm Flagship Ventures Joins a Merck Fund in Launching Biotech Startups | 04-10-12 |
| Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote for the Election of All Illumina Nominees Using Management's WHITE Proxy Card | 04-10-12 |
| Amgen to Pick Up Peptide Drug Firm KAI Pharmaceuticals for $315M | 04-10-12 |
| AVI BioPharma Weighs Next Steps After Mixed Phase II Results with DMD Therapy | 04-06-12 |
| Helix BioPharma Corp. Reconstituted Board of Directors Provides
Update to Shareholders | 04-05-12 |
| Lawmaker Criticizes Continued Development of Pure-Hydrocodone Drugs | 04-05-12 |
| Sucampo Reports Positive Phase III Results in Opioid-Induced Bowel Dysfunction | 04-05-12 |
| Spectrum to Spend $206M to Purchase Allos Even as Late-Stage Cancer Drug Fails | 04-05-12 |
| GE Snags Sequencing Services Firm SeqWright | 04-05-12 |
| Spectrum to Spend $206M to Purchase Allos Even as Phase III Cancer Drug Fails | 04-05-12 |
| 2-to-1 Majority of Respondents to a GEN Poll See Smooth Sailing Ahead for Vivus' Obesity Therapy | 04-04-12 |
| Carl Icahn Takes Aim at Amylin Board, After BMS' Acquisition Offer | 04-04-12 |
| OvaScience Scores $37M in Series B Financing to Advance Fertility Treatment | 04-04-12 |
| New York Genome Center Gets $3M from Sloan Foundation | 04-04-12 |
| Novartis Looks to Turkey for Emerging Markets HQ | 04-03-12 |
| New York Genome Center Gets $3M from the Sloan Foundation | 04-04-12 |
| Sigma-Aldrich Purchases Research Organics for Pharma-Grade Raw Materials | 04-03-12 |
| Illumina Shuns Roche's Improved Acquisition Offer of $6.5B | 04-03-12 |
| AlloCure Pockets $25M for Acute Kidney Injury Stem Cell Therapy | 04-02-12 |
| More Than Half the Respondents to a GEN Poll Support a Ban on Chimps in Research | 04-02-12 |
| Ingenuity, Life Tech Introduce Solution for Real-Time PCR Gene-Expression Analysis | 04-02-12 |
| Report Urges EU Nations to Boost R&D Through Tax, Regulatory Policies | 03-30-12 |
| Amylin Pharmaceuticals, Inc. and Illumina, Inc. Benefit From JOBS Act | 03-30-12 |
| Human Genome Sciences, Inc. and Halozyme Therapeutics, Inc. Future
Looks Promising With Senate Passing of JOBS Act | 03-30-12 |
| Royalty Pharma to Pay Sunesis $25M for Future Royalties from AML Drug Sales | 03-30-12 |
| Abbott Achieves CE Mark for PLEX-ID Microbial Identification Technology, Assays | 03-30-12 |
| Abbott Achieves CE Mark for PLEX-ID Microbial Identification Platform and Assays | 03-30-12 |
| Royalty to Pay Sunesis $25M for Future Royalties from AML Drug Sales | 03-30-12 |
| Beckman Coulter Life Sciences Takes Over Blue Ocean Biomedical | 03-30-12 |
| GEN Poll Respondents See Euro Crisis Casting a Shadow on U.S. Biopharma Industry | 03-29-12 |
| Amylin Reportedly Rejected Bristol-Myers Squibb's $3.5B Takeover Offer | 03-29-12 |
| Illumina Advises Stockholders to Defer Taking Any Action in Response to Roche's Increased Offer | 03-29-12 |
| Roche Ups Bid for Illumina to $51 Per Share, or $6.5B | 03-29-12 |
| House Joins Senate in Passing JOBS Act, Promising Relief for Biopharma Startups | 03-28-12 |
| Goldman Sachs Points to Possible Three-Phase Breakup of Pfizer Businesses | 03-27-12 |
| AB SCIEX Announces Academic Partnership Program to Support Biological Research | 03-27-12 |
| Celtic Pledges $50M to Establish Business to Develop Antibody-Drug Conjugates | 03-26-12 |
| Enterome Raises ?5M to Develop Gut Bacteria-Based Disease and Drug-Response Biomarkers | 03-23-12 |
| Enterome Raises ?5M to Develop Gut Bacteria-Based Disease and Drug Response Biomarkers | 03-23-12 |
| GSK Confirms £500M Investment in Manufacturing Across Multiple U.K. Sites | 03-22-12 |
| Watson Rumored to Be Talking to Actavis About a ?5B Acquisition Deal | 03-22-12 |
| Lilly CEO Discusses Plans to Double Growth in China | 03-21-12 |
| Index Ventures Launches ?150M Life Sciences Fund with GSK, J&J | 03-21-12 |
| Cytos to Secure up to CHF 37M to Advance Phase II Asthma Immunotherapy | 03-21-12 |
| Index Ventures Launches ?150M Life Sciences Fund with GSK and J&J | 03-21-12 |
| Supreme Court Unanimously Overturns Prometheus Dosage Calibration Method Patent | 03-20-12 |
| Supreme Court Unanimously Overturns Prometheus Dosage Calibration Method Patent, Siding with Mayo | 03-20-12 |
| FDA Should Not Relax Conflict Rules for Advisory Panel Members, GEN Poll Notes | 03-20-12 |
| Cepheid Gets $1.3M to Develop Sample Prep Methods for Detecting Bloodstream Bacteria | 03-20-12 |
| Alzheimer's Association Puts $4.2M into Initiative to Speed Drug, Biomarker Trials | 03-20-12 |
| Big Pharma Saw an Almost One-Third Drop in Patent Filings Between 2007 and 2009 | 03-20-12 |
| Wellcome Trust to Set Up £200M Investment Business Focused on Startups | 03-20-12 |
| Alzheimer's Association Puts $4.2M into Initiative to Speed Drug and Biomarker Trials | 03-20-12 |
| Currency Exchange Rates Deflate Sales, Profits for 75 Publicly Traded Pharmas in India | 03-19-12 |
| Illumina Files Definitive Proxy Materials and Sends Letter to Stockholders | 03-19-12 |
| XTL Inks Agreement with Clalit to Aid Product Development | 03-16-12 |
| India's Proposed Budget Offers Some More Incentives, Taxes for Biopharma | 03-16-12 |
| Grifols Nabs 51% Stake in Alzheimer Disease Dx, Vaccines Firm Araclon | 03-16-12 |
| XTL Inks Framework Agreement with Clalit to Aid Product Development | 03-16-12 |
| Grifols Nabs 51% Stake in Alzheimer Disease Dx and Vaccines Firm Araclon | 03-16-12 |
| Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego | 03-15-12 |
| Report Cautions More Drugs, Diagnostics Needed in Europe for Multiple Sclerosis | 03-14-12 |
| $6.2M Investment in Mucosal Drug Firm Kala Completes $11.2M Seed Financing | 03-14-12 |
| Nearly Half the Respondents to a Recent GEN Poll Foresee No Job Cuts Where They Work | 03-13-12 |
| India Orders First Compulsory License for Bayer's Nexavar Cancer Drug to Natco | 03-13-12 |
| Recent Poll Results Highlight How Divisive Gene Patenting Is | 03-12-12 |
| OriGene Takes Over Pathology Reagent Company Zhongshan Golden Bridge Biotechnology | 03-13-12 |
| FDA Approves Organogenesis? Gintuit Cell-Based Product for Gum Disease | 03-12-12 |
| Immunovaccine Joins with Weill Cornell Medical College to Advance
Anti-Cocaine Vaccine | 03-12-12 |
| Roche CEO Sings China's Praises Noting Country's Interest in the Industry | 03-07-12 |
| Aragon Raises $42M to Progress Prostate and Breast Cancer Drugs | 03-07-12 |
| GE Healthcare to Snag Xcellerex for Single-Use Manufacturing Technology | 03-07-12 |
| Alverix Continues Expansion of Its Intellectual Property Portfolio with the Addition of Two Key Patents | 03-07-12 |
| USPTO Rejects Butamax's Self-Described ?Foundational? IP Claims in Successful Gevo Reexamination Petition | 03-06-12 |
| Russian Tech Fund Joins U.S. VC Firm in $760M Biopharma Venture | 03-06-12 |
| 4s3 Raises $20M to Create Protein Therapies for Orphan Neuromuscular Disorders | 03-06-12 |
| Dr. Guttman, Invited Expert Panelist for America Invents Act Webinar Entitled "What Biomedical Companies & Entrepreneurs Need to Know" | 03-06-12 |
| Fast Forward to Provide Funding for Concert's MS Spasticity and Pain Candidate | 03-05-12 |
| Vascular Magnetics Raises $7M to Develop Magnetically Targeted Nanoparticles for PAD | 03-02-12 |
| Biotech Leaders Oppose Washington State Plan to Cut Tax Credit to Aid High-Tech Education | 03-01-12 |
| Illumina Announces Outcome of First Phase of Its Patent Litigation Against LadaTech, LLC | 03-01-12 |
| Dainippon Sumitomo Pharma to Snag Boston Biomedical for $200M | 02-29-12 |
| Micromet Shareholders Seeking to Torpedo $1.16B Amgen Merger | 02-28-12 |
| C3 Jian Raises $30M to Take Peptide-Based Tooth Decay Candidate into Clinical Trials | 02-28-12 |
| OPKO Invests in BioZone Pharmaceuticals, Inc. | 02-27-12 |
| Satori Secures $15M to Further Preclinical Alzheimer Drugs | 02-23-12 |
| Sanofi to Shutter Genzyme's R&D Site in Cambridge, U.K. | 02-22-12 |
| Florida Institute for the Commercialization of Public Research Appoints Entrepreneur Jamie Grooms As New CEO | 02-22-12 |
| EMA Green-Lights Shire's Manufacturing Site in Lexington, MA, for Gaucher Therapy | 02-22-12 |
| NetStar-1 and Whitney, Bradley and Brown, Inc. Merge | 02-22-12 |
| Omeros Wins $1.04M NIDA Grant to Progress NMUR2 Inhibitor Analgesics | 02-21-12 |
| Novartis Pays Enanta $34M UP Front for Worldwide Rights to HCV HS5A Inhibitors | 02-21-12 |
| MPEG LA's Librassay® Featured in Genetic Diagnostic Testing Testimony at USPTO | 02-16-12 |
| BioSante, Teva Win FDA Nod for Male Hypogonadism Therapy | 02-16-12 |
| Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Animal Feed | 02-16-12 |
| Illumina Announces Favorable Patent Claim Construction Ruling in Litigation Against Complete Genomics, Inc. | 02-16-12 |
| NIH's TRND Program Will Boost Rare and Neglected Disease Drug Development, GEN Voters Say | 02-15-12 |
| Biogen Idec Pledges $75M to Acquire Stromedix | 02-14-12 |
| Organovo Raises $6.5M to Advance 3-D Tissue Printing Platform | 02-15-12 |
| Karo Bio Axes Clinical Dyslipidemia Program After Side Effects Surface in Animal Study | 02-14-12 |
| Dow AgroSciences Announces Major U.S. Asset Investment Related to Enlist Weed Control System | 02-14-12 |
| Karolinska Development Establishes KDev Oncology to Corral Cancer Projects | 02-13-12 |
| Valeant Pharmaceuticals to Take Over Eyetech | 02-13-12 |
| SeraCare to Be Bought by Linden Capital Partners | 02-13-12 |
| New Estimate Sharply Raises Projected Cost of Developing a New Drug | 02-13-12 |
| Karolinska Develpment Establishes KDev Oncology to Corral Cancer Projects | 02-13-12 |
| DR Systems Announces Issuance of U.S. Patent for Matching Medical Images | 02-13-12 |
| Voters Split on Expanding a Biodefense Program Beyond the Former USSR | 02-10-12 |
| Pharma's High Number of January Layoffs Driven by a Handful of Companies | 02-10-12 |
| With Progress on Debt Accord, Greece Scrambles to Cut Pharma Costs | 02-09-12 |
| FDA Issues Draft Guidance for Getting Biosimilars Approved | 02-09-12 |
| Cytomedix Picks Up Stem Cell Therapy Firm Aldagen | 02-09-12 |
| U.S. Drug Manufacturing Decline Reflects Wage Gap and Regulatory Scrutiny | 02-08-12 |
| Sistemic Joins ?5.9M TiGenix-Led EU Consortium to Develop Stem Cell Rheumatoid Arthritis Therapy | 02-08-12 |
| Illumina Shuns Roche's $5.7 Bid, While Roche Prepares for the Long Haul | 02-08-12 |
| California Agency Helpful in Advancing Stem Cell Science, According to GEN Poll | 02-07-12 |
| L-3 Completes Acquisition of Kollmorgen Electro-Optical | 02-07-12 |
| NIH Will Pay for Salary Cap with GEN Poll Predicting Researchers Will Migrate to Industry | 02-07-12 |
| GSK Counts on R&D Cost Savings, Pipeline Progress to Deliver Better Results in 2012 | 02-07-12 |
| BSD Medical Launches New Online Investor Center | 02-07-12 |
| Audax Group Announces the Acquisition of Advanced Dermatology & Cosmetic Surgery | 02-06-12 |
| UPenn Cancer Institute's Suit Against Ex-Director Reflects Greater Focus on IP Protection | 02-06-12 |
| Agennix Stops Phase II/III Talactoferrin Study in Sepsis Due to Higher Death Rates | 02-03-12 |
| PDUFA V Supporters Try to Sell Congress on Job, Innovation Potential | 02-02-12 |
| Athersys? MultiStem Program Gets $3.6M Boost | 02-02-12 |
| Shire, Sangamo Ink $13M Up-Front Deal for ZFPs against Hemophilia and Monogenic Disorders | 02-01-12 |
| Roche's Cobas Test for Chlamydia and Gonorrhea Granted 510(k) Clearance in U.S. | 02-01-12 |
| FDA Sanctions Vertex? Kalydeco for Treating Cystic Fibrosis Caused by G551D Mutations | 02-01-12 |
| FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery | 02-01-12 |
| Exosome, LMU Awarded ?1M to Develop Blood-Based Exosome Diagnostics for Cancer | 02-01-12 |
| Shire, Sangamo Ink $13M Up front Deal for ZFPs against Hemophilia and Monogenic Disorders | 02-01-12 |
| Poll on 'strategy for UK Life Sciences? Shows Divide | 01-31-12 |
| Pfizer Expands Equine Interests | 01-31-12 |
| New GM Admits Global Fund to Fight AIDS, Tuberculosis and Malaria Needs Fixing | 01-30-12 |
| Oshkosh Corporation Reports Fiscal 2012 First Quarter Results | 01-31-12 |
| FDA Clears Roche's Erivedge for Treating Advanced Basal Cell Carcinoma | 01-31-12 |
| Pfizer's Inlyta Approved in U.S. as Therapy for Advanced Renal Cell Carcinoma | 01-31-12 |
| BTG's Varicose Veins Therapy Meets All Endpoints in First U.S. Pivotal Trial | 01-30-12 |
| Transgene Makes Moves to Fortify Presence in China | 01-30-12 |
| Amgen Ponies Up $1.16B to Buy Micromet for Its mAb Technology | 01-26-12 |
| Illumina Institutes Poison Pill to Ward off Roche's $5.7B Purchase Proposal | 01-26-12 |
| NIH Won?t Survive FY 2013 Without Budget Reduction, GEN Poll Predicts | 01-25-12 |
| FDA Clears Leo's Picato Gel for 2?3 Day Treatment of Actinic Keratosis | 01-26-12 |
| President Obama Restates Case for Basic Research in State of the Union Address | 01-25-12 |
| Roche Outlines $5.7B Bid to Buy Illumina for $44.5 Per Share in Cash | 01-25-12 |
| EC Okays Merck Serono's Rebif for Patients With Early Stages of MS | 01-25-12 |
| Prosensa Raises ?23M to Progress Exon-Skipping Antisense Oligonucleotides | 01-25-12 |
| FDA Gets Top Grades for Bringing New Drugs to Market from Most GEN Voters | 01-24-12 |
| Growth of Corporate Ventures Reflected in Rising VC Numbers | 01-24-12 |
| Nutritional Therapeutics, Inc. (US) and Nutri-Link Ltd. (UK) Announce Strategic Alliance for the Introduction of a New Therapy for European Healthcare Practitioners | 01-24-12 |
| Market Ready Rx? Expands Presence with New Executive Search Business | 01-24-12 |
| Aphios Pockets $2.4M SBIR Grant for Preclinical Alzheimer Disease Candidate | 01-24-12 |
| MDxHealth Awarded CLIA Certification for Irvine Laboratory | 01-23-12 |
| OPKO Health Acquires Next Generation Prostate Cancer Tests | 01-23-12 |
| EntreMed Raises $10M To Progress Clinical Anticancer Pipeline and Expand R&D | 01-23-12 |
| Cell Therapeutics, Inc. Expects That the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri? in Mid-February | 01-20-12 |
| Capstone Therapeutics Drops Drug Development due to Pending Whistle-Blower Law Suit | 01-20-12 |
| Biopharma Investment Grows During Q4 but VCs Fund Fewer Early Deals | 01-20-12 |
| GEN Poll Voters Divided on Prospects for Growth of Emerging Bioclusters | 01-18-12 |
| Quintiles Takes Majority Stake in Oxford Cancer Biomarkers | 01-18-12 |
| Bayer Plans 2012 Filing for Regorafenib Following Positive Phase III mCRC Trial Results | 01-18-12 |
| FDA Clears BTG's Voraxaze for Treating Methotrexate Toxicity | 01-18-12 |
| Pherecydes Receives Grant to Develop Bacteriophage Therapies for Skin Infections | 01-18-12 |
| CIRM to Put $40M into Stem Cell Genomic Centers | 01-18-12 |
| Takeda Lets Go of 2,800 Employees to Integrate Newly Acquired Nycomed | 01-18-12 |
| USPTO Balks at Grant/Loan Program to Help Startups Protect Patents | 01-17-12 |
| Janssen Starts Open Innovation Lab in San Diego | 01-17-12 |
| Poll on the IPO Market This Year Has Voters Nearly Evenly Split | 01-16-12 |
| Life Technologies, DaAn Establish Chinese Diagnostics Joint Venture | 01-17-12 |
| Janssen's Starts Open Innovation Lab in San Diego | 01-17-12 |
| Novartis Plans $450M Cost Cuts to Shoulder Diovan Patent Loss, Aliskiren Safety Concerns | 01-13-12 |
| M&A Activity in 2012 Will Surpass Last Year's Pace, GEN Online Readers Predict | 01-12-12 |
| Ion Torrent Instrument Designed to Sequence the Human Genome for $1,000 in One Day | 01-10-12 |
| Mentor Capital Begins its 2012 Cancer Roll-up Strategy with $10 Million in Private Medical Company Acquisitions | 01-10-12 |
| BMS To Buy Anti-Infectives Firm Inhibitex for $2.5B in Cash | 01-10-12 |
| Third Rock, Sanofi Launch Drug Discovery Firm, Warp Drive, with $125M | 01-10-12 |
| U.K.'s Technology Strategy Board Awards £900K to Stem Cell Research Consortium | 01-10-12 |
| Kadmon Acquires First-in-Class Ras Antagonist From Concordia
Pharmaceuticals | 01-09-12 |
| BerGenBio Raises $8.8M to Advance Axl Kinase Inhibitor Drug Into Clinical Trials | 01-09-12 |
| Sigma-Aldrich Snaps Up BioReliance for $350M | 01-09-12 |
| Akebia Spins out Aerpio to Develop Tie-2 Activators and HIF-1a Stabilizers | 01-09-12 |
| Celtaxsys Takes Over Estrellita's Anti-Inflammation Therapy | 01-06-12 |
| Predictive Data Modeling in Life Science Research Wins Support from GEN Poll Voters | 01-05-12 |
| Gene Security Network Closes $20M Round, Changes Name to Natera | 01-06-12 |
| Midatech Secures £6.3M to Develop Chemotherapeutic Gold Nanoparticles | 01-05-12 |
| Apogenix Raises ?7.5M to Progress Glioblastoma Drug Through Phase II | 01-05-12 |
| Roche Gets CE Clearance for Two HCV Molecular Diagnostics | 01-05-12 |
| Midatech Secures £6.3M Financing to Develop Chemotherapeutic Gold Nanoparticles | 01-05-12 |
| $30M Funding Will Allow Elevation to Take Nebulized LAMA for COPD into Phase III | 01-04-12 |
| Pharmlink Raises SEK35M for Late-Stage Development of Nefecon and Busulipo | 01-04-12 |
| Probiodrug Secures ?15M to Progress Glutaminyl Cyclase Inhibitor Alzheimer Drug | 01-04-12 |
| Abbott Biotech Ventures Invests in NeuroGenetic Pharmaceuticals | 01-04-12 |
| Probiodrug Secures ?15M to Progress Glutaminyl Cyclase Inhibitor Alzheimer Drug | 01-04-12 |
| Green River Capital Concludes Another Year of Giving with "Sub for Santa" | 01-04-12 |
| Baron and Budd Announces $8.4 Million Verdict for Widow of Mesothelioma Cancer Patient | 01-03-12 |
| Readers Show Confidence in FDA's Biosimilar User Fee Framework | 01-03-12 |
| SCRA Announces Public Audit Results for Fiscal Year 2011 | 01-03-12 |
| Nearly Even Split Among Voters on Amgen's Ability to Fend Off Enbrel Biosimilars | 01-03-12 |
| Accelrys Picks Up VelQuest with $35M to Bolster Informatics Offerings | 01-03-12 |
| Phase III Results Lead Aveo and Astellas to Plan Regulatory Submissions for Tivozanib | 01-03-12 |
| TrovaGene Gains Rights to Mutations Associated with Chronic Lymphocytic Leukemia | 01-03-12 |
| Apogenix Wins ?2.3M Grant to Develop Fusion Protein Against Myelodysplatic Syndrome | 01-03-12 |
| Readers Divided on Potential Success of Barack Obama's Bioeconomy Blueprint | 12-30-11 |
| Johns Hopkins Gets $9.5M for Asthma Genome Project Focused on African-Americans | 12-30-11 |
| Poll Respondents Mostly Confident U.S. Can Protect Second-Opinion Genetic Test Developers | 12-30-11 |
| AMT Raises ?2.5M but Says Future Still Hangs in the Balance | 12-30-11 |
| 2-to-1 Majority Confident Federal Efforts Will Maintain U.S. Leadership in Nanotech | 12-29-11 |
| Even Split on OS vs. PFS As Primary Endpoint for Cancer Drug Approvals | 12-28-11 |
| New York Genome Center Expected to Boost City's Biotech Presence | 12-27-11 |
| Xenome Secures about $6.2M to Advance Peptide-Based Pain Med | 12-23-11 |
| Narrow Plurality Sees High Court Siding with Mayo Over Prometheus in Dx Patent Case | 12-22-11 |
| Fish & Richardson joins the Obsidian Team to Manage a Growing Intellectual Property Portfolio | 12-22-11 |
| Celek Wins NCI Grant for Bladder Cancer Drug | 12-22-11 |
| FDA Sanctions Merck & Co.'s Isentress for Use in HIV-1 Children, Teens | 12-22-11 |
| LabCorp® Enters into New Credit Facility Totaling $1.0 Billion | 12-21-11 |
| Takeda to Pick Up Intellikine for $190M | 12-21-11 |
| Genzyme Reports Data from Late-Stage MS Study | 12-20-11 |
| ArGEN-X Obtains ?1.3M to Advance Antibody Platform | 12-19-11 |
| Poll Majority Confident Russia Can Grow Biopharma to 5% Global Share by 2020 | 12-19-11 |
| Pall to Take Over ForteBio for Protein Analysis Systems | 12-19-11 |
| FDA Clears Hologic's Automated Platform for Cervical Cancer Cervista HPV Assay | 12-16-11 |
| Valeant Proposes $314M Take Over of ISTA to Its Board of Directors | 12-16-11 |
| Standard of Care, Overseas Opportunities Top Strategies Firms Use to Overcome MDX Reimbursement Issues | 12-16-11 |
| Valeant Proposes $314M Take Over of ISTA to Its Board of Director | 12-16-11 |
| AHF Launches Campaign Against AIDS Discrimination at Hershey School | 12-15-11 |
| Voters Divided on What Congress Will Do About NIH in FY 2012 | 12-15-11 |
| CardioNet, Inc. Reaches Preliminary Agreement on Shareholders Litigation | 12-15-11 |
| Ember Therapeutics Launched with $34M to Focus on Metabolic Disorders | 12-15-11 |
| Essilor Acquires Stylemark, a Leading US Distributor of Non-Prescription Glasses | 12-14-11 |
| Poll Voters Believe Geron Will Find a Partner for hESC Therapeutic Programs | 12-13-11 |
| Quintiles Deepens China Commitment with New CRO | 12-13-11 |
| IntegenX Scores $40M to Commercialize DNA Identification System | 12-13-11 |
| House, Senate Agree to Six-Year SBIR Reauthorization | 12-13-11 |
| L-3 Agrees to Acquire Kollmorgen Electro-Optical | 12-13-11 |
| Rainbow to Snap Up n3D's Three-Dimensional Cell Culturing Technology | 12-12-11 |
| Rainbow Snaps Up n3D's Three-Dimensional Cell Culturing Technology | 12-12-11 |
| Ariad Reports Positive Preliminary Results from Pivotal Ponatinib CML Trial | 12-12-11 |
| Leading Training and Security Services Provider Xe Services Announces Name Change to ACADEMI | 12-12-11 |
| Roswell Park Cancer Institute Gets $5.1M for Sequencing Effort in New York | 12-12-11 |
| Rainbow Snaps Up n3D's Three Dimensional Cell Culturing Technology | 12-12-11 |
| Clarient, Acorn Ally to Standardize Cancer Testing | 12-09-11 |
| CIRM Okays $27M for Two Funds, Proposes Stem Cell Bank with $30M in Awards | 12-09-11 |
| Washington Should Help Smaller Biotechs Gain International IP Protection According to Poll | 12-08-11 |
| Roche's Pertuzumab Improved PFS in Her2+ Metastatic Breast Cancer | 12-08-11 |
| GEN Readers Confident Biotech Tool Companies Will Survive Through Consolidation | 12-07-11 |
| Gevo Receives Key Patent from USPTO for Efficient Production of Isobutanol | 12-06-11 |
| Alzheimer's Disease Patent Issued to New Mexico Physicist Edward R. Flynn, Ph.D | 12-06-11 |
| Merck & Co. Establishes Asian R&D Headquarters in Beijing | 12-06-11 |
| Even Split on Whether Federal Circuit Will Change Akamai, McKesson Decisions | 12-05-11 |
| Corning Adds Mediatech to Life Science Segment | 12-02-11 |
| Agilent Picks Up Halo Genomics and BioSystem Development | 12-02-11 |
| Prosensa Gets $1.5M for R&D in Duchenne Muscular Dystrophy | 12-01-11 |
| Senate Moves Toward SBIR Reauthorization for Eight Years | 12-01-11 |
| Charley's Fund Gives Prosensa $1.5M for R&D in Duchenne Muscular Dystrophy | 12-01-11 |
| Ranbaxy Launches Generic Lipitor in the U.S. | 12-01-11 |
| arGEN-X Raises $37M to Progress mAb Pipeline | 12-01-11 |
| VGTI-FL Scientists Awarded Fellowships for AIDS Research Projects | 11-30-11 |
| Nearly Two-to-One Majority Sees FDA or EMA Approval of Gene Therapy by 2013 | 11-30-11 |
| UC San Diego to Use Thermo Fisher Scientific Fluorospectrometer | 11-30-11 |
| Two-to-One Majority Differs with European Court Ruling Against Patenting hESCs | 11-29-11 |
| Expedeon, Protein Discovery Ink Merger Deal | 11-29-11 |
| AHF Renews Call for Global Fund Head to Step Down | 11-29-11 |
| UltiSat Awarded GSA IT Schedule 70 Contract | 11-28-11 |
| PPG to Host Capital Markets Meeting and Webcast Dec. 5 in New York City | 11-28-11 |
| Radius Raises $26.75M for Phase III Osteoporosis Trial | 11-23-11 |
| Celgene Nixes Revlimid Prostate Cancer Trial | 11-23-11 |
| FDA Okays Regeneron's Wet AMD Therapy | 11-22-11 |
| Cedars-Sinai to Serve as Roche Center of Excellence | 11-22-11 |
| Pfizer to Pick Up Antisense Firm Excaliard | 11-22-11 |
| FDA Okay's Regeneron's Wet AMD Therapy | 11-22-11 |
| LED Lighting to Capture 52% of the Commercial Building Market by 2021, According to Pike Research | 11-22-11 |
| Overlake's Heart and Vascular Center Construction Project Receives $1 Million Gift | 11-21-11 |
| Valeant to Buy iNova for A$625M Up Front | 11-21-11 |
| Gilead Ponies Up $11B to Purchase Pharmasset | 11-21-11 |
| The Halifax Group Makes Investment in XL Associates | 11-21-11 |
| FDA Revokes Avastin Indication for Treatment of Metastatic Breast Cancer | 11-18-11 |
| FDA Clears EUSA's Asparaginase Therapy Erwinaze for Acute Lymphoblastic Leukemia | 11-18-11 |
| Key Patents Issued to Celerus Diagnostics | 11-18-11 |
| House, Senate Approve FY 2012 Funding Levels for FDA, NSF, NIST, and OSTP | 11-17-11 |
| Agios Secures $78M to Progress Cancer Metabolism-Targeting Drugs into Clinic | 11-17-11 |
| Pfizer's Vyndaqel Gets EC Approval for Transthyretin Familial Amyloid Polyneuropathy Therapy | 11-17-11 |
| Biocartis Scores ?71M to Commercialize a Point-of-Care Molecular Diagnostic | 11-17-11 |
| Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase I/II | 11-17-11 |
| ManTech Completes Acquisition of Worldwide Information Network Systems | 11-16-11 |
| Harris Corporation Named Among World's 100 Most Innovative Companies | 11-15-11 |
| Bluestone Closes Fund Focused on Small Defense and Government Services Businesses | 11-15-11 |
| CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on ?33.1M DARPA-Supported Vaccine Program | 11-15-11 |
| Synergy Pharmaceuticals Obtains $5.64M Financing | 11-15-11 |
| Geron Sidelines Stem Cell Programs and Cuts Workforce to Focus on Clinical Cancer Candidates | 11-15-11 |
| Altus Capital Partners II, L.P. Acquires Models & Tools, a Leading Supplier of Advanced Tooling Systems for the Aerospace and Defense Industries | 11-15-11 |
| Daylight Solutions? Continued Investment in Manufacturing Infrastructure Yields Increased Capacity to Meet Customer Demand | 11-15-11 |
| The Data-Enabled Life Science Alliance Receives Grant from Moore Foundation | 11-14-11 |
| Labindia Divests Businesses to AB Sciex and Leica | 11-14-11 |
| Phase III Study Demonstrates Benefits of Janssen's Xarelto in Acute Coronary Syndrome | 11-14-11 |
| Leica Microsystems Acquires Labindia's Microscopy and Histopathology Divisions | 11-14-11 |
| FDA Sanctions NYBC's Cord Blood Hematopoietic Progenitor Cells for Transplantation | 11-11-11 |
| FDA Lifts Hold on Start of Helix? Trial for Topical Treatment for Cervical Lesions | 11-11-11 |
| Alcoa Foundation Partners With Veterans Organizations to Support Our National Heroes | 11-11-11 |
| FDA Lifts Hold on Start of Helix? Topical Treatment for Cervical Lesions | 11-11-11 |
| FDA Lifts Hold on Start of pivotal Trial with Helix's Topical Treatment for Cervical Lesions | 11-11-11 |
| Mintz Levin Represents Homeland Security Capital Corporation in $19.4 Million Sale of its Subsidiary | 11-10-11 |
| GE Software Powers Research on Efficient Wind Energy Production | 11-10-11 |
| Avaxia Raises $2.2M to Take Oral Antibody IBD Candidate into Clinical Trials | 11-10-11 |
| International Stem Cell Corporation Announces the Launch of Two New International Sales Initiatives for Lifeline Skin Care | 11-10-11 |
| BARDA Rejects Maxygen's Proposal to Develop MAXY-G34 for Acute Radiation Syndrome | 11-10-11 |
| CACI Awarded Four Contracts Worth $69 Million to Support Defense Medical Logistics Systems | 11-10-11 |
| Applications Now Being Accepted for the 2012 Norman S. Coplon Extramural Grants | 11-09-11 |
| Jack in the Box® Holiday Elves Raise Funds for Big Brothers Big Sisters | 11-09-11 |
| Industry Experts Briefed on Bio-Intervention Specialists? Electro-BioCide, an Innovative Disinfectant for Reducing Hospital-Acquired Infections | 11-09-11 |
| Salix Acquires Oceana Therapeutics for $300M | 11-09-11 |
| GEN Wins Best Business-to-Business Award from Folio Magazine | 11-09-11 |
| BGI and The Children's Hospital of Philadelphia Set Up Genome Center to Target Pediatric Diseases | 11-09-11 |
| Maven Semantic: Acquired Immunodeficiency Research Database | 11-09-11 |
| Waters Corporation Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference to be Webcast Live | 11-08-11 |
| ORCA Therapeutics Wins ?5M Innovation Credit to Develop Oncolytic Adenoviruses | 11-08-11 |
| Amylin to Pay Lilly $250M to End Exenatide Partnership and Litigation | 11-08-11 |
| Triumph Group Announces Commencement of Public Offering of Common Stock | 11-08-11 |
| ORCA Therapeutics Wins ?5M Innovation Credit to Oncolytic Adenovirus | 11-08-11 |
| Early Fuel Cell Activity is Creating New Markets for Hydrogen, According to Pike Research | 11-08-11 |
| Triumph Group Announces Public Offering of Common Stock | 11-07-11 |
| NanoString Scores $20M Series D Financing to Progress Diagnostic Platform | 11-07-11 |
| COPT Signs 103,000 Square Foot Lease at Patriot Ridge in Springfield, Virginia | 11-07-11 |
| GE and Juniper Networks to Develop Family of Rugged, Secure Network Appliances for Military Vehicles | 11-07-11 |
| Cracker Barrel Offers Thanks to Veterans with Red, White & Blue Limited Edition Signature Peg Game | 11-04-11 |
| ManTech Awarded DHS Contract to Continue Providing Information Technology Services in Support of the SAFETY Act | 11-04-11 |
| AHF: AIDS Patients File Ohio Lawsuit to Halt Illegal Restrictions on AIDS Drug Access | 11-04-11 |
| New Department of Labor Grants Offer Training and Certification Opportunities for American Workforce | 11-03-11 |
| Susan G. Komen for the Cure® Grants $750,000 to Help Reduce Higher Breast Cancer Death Rates among African American Women in St. Louis | 11-03-11 |
| Susan G. Komen for the Cure® Launches Wyoming Program to Improve Screening, Care for Rural U.S. Women | 11-03-11 |
| South Carolina's $1 Billion Economic Development Research Program to Showcase Economic Successes at National Conference in December | 11-03-11 |
| URS Selected for U.S. Navy and U.S. Marine Corps Acquisition and Technical Support Contract | 11-03-11 |
| South African Sugar Industry Standardizes on Bruker FT-NIR Systems | 11-03-11 |
| Theragenics Reports Revenue and Earnings for Third Quarter 2011 | 11-03-11 |
| Defense Holdings, Inc. to Provide Safety Markings and EXIT Signs for Army National Guard Headquarters | 11-03-11 |
| Kaman Announces Acquisition of Vermont Composites | 11-02-11 |
| V-Tech Solutions, Inc. Wins $4.1 Million Forensic Accounting Contract Supporting U.S. Forces in Afghanistan | 11-02-11 |
| Exactech Q3 Revenue Up 13% to $47.3M Driven by Robust International Growth | 11-01-11 |
| Purdue Research Foundation to Honor 59 University Entrepreneurs, Researchers | 11-01-11 |
| Karbon Arms Sues Taser Distributor Vance Outdoors for Violation of Lanham Act, Tortious Interference and Libel | 11-01-11 |
| Bulova Technologies Group, Inc. CEO Stephen Gurba Conducts Exclusive Webcast Interview with The Green Baron Report | 11-01-11 |
| In-Situ Inc. Announces Acquisition of PR Aqua Supplies Ltd. | 11-01-11 |
| SIFCO Industries, Inc. Announces the Acquisition of the Forging Business and Related Assets from GEL Industries, Inc. (DBA Quality Aluminum Forge) | 11-01-11 |
| Triumph Group Announces Acquisition | 10-31-11 |
| Sterne Agee Announces Senior Additions to Equity Research Team | 10-31-11 |
| Argentum Medical LLC Announces Patent Reexamination Results for Silverlon® Antimicrobial Wound, Burn and Surgical Dressings | 10-31-11 |
| FDA Clears Gen-Probe's mRNA-Based HPV Assay for Use Alongside Pap Tests | 10-31-11 |
| Brazilian, Russian, Indian and Chinese Electrophysiology Mapping and Ablation Markets to More Than Double by 2016 | 10-31-11 |
| Xylem launches as new global, pure-play water technology company | 10-31-11 |
| ITT Reports Solid Third-Quarter Results on Strength Across All Segments; ITT Exelis and Xylem Spinoff Transactions Set to Occur on October 31 | 10-28-11 |
| Essay Contest: Who Is the Steve Jobs of Biotechnology? | 10-28-11 |
| ITC Finds Multiple Patent Infringement by Suprema and Mentalix, Issues Exclusion Order and Cease and Desist Order | 10-27-11 |
| Quintiles to Buy Advion's Bioanalytical Services Division | 10-27-11 |
| California Institute for Reg Med Agrees to Dole Out $30M to Foster Alliances with Industry | 10-27-11 |
| Selecta and Bind Each Obtain $47.25M from Russian Federation Fund | 10-27-11 |
| ManTech to Acquire Worldwide Information Network Systems, Inc. | 10-27-11 |
| Charter Pacific Announces Mauritania Iron Ore Exploration Programme Proceeds to Next Stage | 10-27-11 |
| Harris Corporation Reports Fiscal 2012 First Quarter Results and Significantly Higher Orders | 10-26-11 |
| HyGreen Called to Washington to Share Solution for Hospital Acquired Infections | 10-26-11 |
| Bayer's Phase III Colorectal Cancer Trial Unblinded After Promising Interim Data | 10-26-11 |
| Late-Stage Study Results Show Dynavax? HBV Vaccine Is Better at Protecting Diabetics than Engerix-B | 10-26-11 |
| Curetis Adds ?9.6M to Series A Financing Round for Diagnostic Development | 10-26-11 |
| Biogen Idec Reports Positive Data from Second Phase III Trial with Multiple Sclerosis Drug | 10-26-11 |
| Senesco Technologies Receives Notice of Non-Compliance from NYSE Amex | 10-26-11 |
| Noninvasive Procedures to Lead Growth in Market for Fat Reduction Devices | 10-26-11 |
| Bard Announces Agreement to Acquire Medivance, Inc. | 10-25-11 |
| Acquired Sales Corp. Announces Letter of Intent to Acquire Defense & Security Technology Group, LLC | 10-25-11 |
| New England Research Institutes Scores $45M to Support the Pediatric Heart Network | 10-25-11 |
| Lilly Pulls Septic Shock Drug Xigris Off the Shelves | 10-25-11 |
| Bostwick Laboratories Completes Growth Recapitalization with Metalmark Capital | 10-25-11 |
| US Women's Health Imaging System Market to Grow to Nearly $1.2 Billion by 2016 | 10-25-11 |
| PrognosDx and Accium to Work on Histone Biomarker Cancer Tests | 10-25-11 |
| Cubist to Pay $190M Up Front for Adolor to Gain Opioid Receptor Antagonists | 10-24-11 |
| WuXi Acquires Chinese Clinical CROs MedKey and Jiecheng | 10-24-11 |
| Harris Corporation Receives $20 Million in Orders to Provide Falcon III AN/PRC-117G Multiband Manpack Radios for U.S. Army and U.S. Marine Corps MRAP Vehicles | 10-24-11 |
| AMAG and Allos Axe $686M Merger After Negative Vote from AMAG Shareholders | 10-24-11 |
| Roche Gives Arrowhead RNAi Assets and Facility in Madison, WI | 10-24-11 |
| Alion Awarded Three Army Task Orders Totaling $8.6M to Help Prioritize Warfighting Capabilities | 10-24-11 |
| ShangPharma Snaps Up Charles River Facility in Shanghai | 10-24-11 |
| Cubist to Pay $190M for Adolor Up Front to Gain Opioid Receptor Antagonists | 10-24-11 |
| Sanofi and Genzyme Report New Positive Data from First Phase III Study with MS Drug | 10-24-11 |
| The International Myeloma Foundation Hosts a Congressional Briefing on Advances in Treating Cancer and the Need for More Biomedical Research | 10-24-11 |
| SCRA-Led Program Reduces Infection Rates, Prevents Hospital Infections | 10-21-11 |
| European Court Bans Patents Based on Embryo Destruction | 10-21-11 |
| Positive Results Reported for Biogen Idec's Oral MS Drug in First Phase III Study | 10-21-11 |
| Zack's Investment Research Initiates Coverage on Corgenix Medical Corporation with ?Outperform? Rating | 10-20-11 |
| Sanofi and Genzyme Report Positive New Data from Phase III Multiple Sclerosis Study | 10-20-11 |
| COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry | 10-20-11 |
| Illumina Leads $8M Financing Round for GenoLogics | 10-20-11 |
| MiMedx Group's Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering | 10-20-11 |
| Companiesandmarkets.com: Airborne ISR Still Viewed as Critical Force Multipliers by Governments | 10-20-11 |
| Florida Announces New Funding Program for University Spinouts | 10-19-11 |
| Sage Licenses Ligand's Captisol Formulation Platform | 10-19-11 |
| Venture Firms Pump $18M into Fledgling Arteaus Therapeutics | 10-19-11 |
| Arsanis Wins ?1.2M for Research on Antibody Against Hospital-Acquired Infections | 10-19-11 |
| Abbott to Split into Two Separate Companies | 10-19-11 |
| Newly Launched CNS Drugs Firm Sage Licenses Ligand's Captisol Formulation Platform | 10-19-11 |
| Gore Acquires Intellectual Property of NMT Medical, Inc. | 10-19-11 |
| Abbott to Split into Two Separate Research-Based Pharmaceuticals and Diversified Medical Products Companies. | 10-19-11 |
| IJJC's Disaster Shelter Management Responder System (DSMRS) Is Positioned as a Winning Solution for Grants | 10-18-11 |
| RTI Announces Agreement to Acquire Titanium Forming Division of Aeromet International PLC | 10-18-11 |
| PPG Finalizes Agreement to Purchase Dyrup A/S, Sets January Closing Date | 10-18-11 |
| Corvus Energy Ltd. Partners with Surrette Battery Company to Sell Co-Branded Lithium-Polymer Batteries | 10-17-11 |
| Watts Water Technologies Appoints New President of North America | 10-17-11 |
| U.S. HealthWorks Acquires 11 Nashville-area Medical Centers | 10-17-11 |
| NeoStem Closes on Amorcyte Acquisition | 10-17-11 |
| BioHelix? IsoAmp Near-Patient HSV Diagnostic Gets FDA 510(k) Clearance | 10-17-11 |
| ONYX Moves to Cash In on Company's New Technology Products | 10-17-11 |
| Tennant Company Promotes Lisa Blocher to Vice President of Global Strategic Accounts | 10-17-11 |
| Sorin Group Invests in Enopace Biomedical, Early Stage Company Focused on Innovative Solution for Heart Failure Patients | 10-17-11 |
| Health Care Mergers and Acquisitions Poised for 20 Percent Growth According to New Report from Irving Levin Associates, Inc. | 10-14-11 |
| Harris Corporation Receives $66.3 Million Order from U.S. Army to Supply Falcon III AN/PRC-117G Manpack Radios for Tactical Network | 10-14-11 |
| Bristol-Myers Squibb Foundation Announces Six New Grants to Bridge Gaps in Cancer Awareness, Prevention and Care in Central and Eastern Europe | 10-14-11 |
| Legion Foundation Awards More Than $500,000 in Grants | 10-13-11 |
| ManTech Closes New $500 Million Credit Facility | 10-13-11 |
| Enanta Wins NIAID Contract Valued at $42.7M to Develop Biodefense Antibiotics | 10-13-11 |
| DNAnexus Raises $15M and Seals Cloud Storage Deal with Google to Host New SRA Database Repository | 10-13-11 |
| Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger | 10-13-11 |
| OPKO Health Announces Acquisition of Claros Diagnostics | 10-13-11 |
| Rolls-Royce and Pratt & Whitney Announce New Partnership to Develop Next Generation Engines for Mid-Size Aircraft and Restructuring of IAE Collaboration | 10-12-11 |
| Alcoa Defense Ships 1,000th M777 Titanium Casting Set | 10-12-11 |
| Oragenics, Inc. Receives U.S. Patent for IVIAT Platform Technology | 10-12-11 |
| Wellcome Trust Gives PsiOxus £1.8M to Take Oncolytic Virus into Clinical Development | 10-12-11 |
| Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification | 10-12-11 |
| Business Wire and CARTES 2011 Consolidate Their Media Partnership | 10-12-11 |
| Companies & Markets: Healthcare Acquired Infection Control Market Set to Hit Over $30bn | 10-12-11 |
| IJJ Corporation is changing its SIC Industry Classification to Manufacturer in preparation for Disaster Shelter Management Responder System (DSMRS) | 10-11-11 |
| Rosetta Genomics to Slash 35 Jobs to Focus on MDx Commercialization in the U.S. | 10-11-11 |
| Neo Solar Power to Invest in BlueChip Energy's 120 MW Sorrento Solar Farm Project | 10-11-11 |
| Mayo Clinic Wins Grant to Study Ethics of Sharing Genetic Test Results with Relatives | 10-10-11 |
| Former Vice Admiral John Morgan Joins Nobles as Executive Chairman | 10-10-11 |
| BAE Systems Showcases Visual Threat Training Simulators at Army Expo | 10-10-11 |
| Datron World Communications Announces Strategic Investment in Aeryon Labs | 10-10-11 |
